60 Degrees Pharmaceuticals Sets Date for Babesiosis Study Data Release, KOL Webinar
60 Degrees Pharmaceuticals, Inc. announced it will disclose interim data from its hospitalized babesiosis study and hold a Key Opinion Leader webinar.
60 Degrees Pharmaceuticals, Inc. announced it will disclose interim data from its hospitalized babesiosis study and hold a Key Opinion Leader webinar.